Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis-Reply

Affiliations

Comment

Shunsuke Furuta et al. JAMA. 2021.

. 2021 Oct 19;326(15):1536-1537.

doi: 10.1001/jama.2021.13879.

¹ Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.

No abstract available

Comment on

Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis.
Jayne DRW, Merkel PA, Bekker P. Jayne DRW, et al. JAMA. 2021 Oct 19;326(15):1536. doi: 10.1001/jama.2021.13873. JAMA. 2021. PMID: 34665208 No abstract available.
Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis.
Kang Z, Li Z. Kang Z, et al. JAMA. 2021 Oct 19;326(15):1535-1536. doi: 10.1001/jama.2021.13867. JAMA. 2021. PMID: 34665209 No abstract available.
Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis.
Chandwar K, Kumar P, Dhakad U. Chandwar K, et al. JAMA. 2021 Oct 19;326(15):1535. doi: 10.1001/jama.2021.13863. JAMA. 2021. PMID: 34665210 No abstract available.